References
- Isaacson PG, Chan JK, Tang C, et al. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus: a thymic lymphoma mimicking myoepithelial sialadenitis. Am J Surg Pathol 1990;14:342–351.
- Inagaki H, Chan JK, Ng JW, et al. Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol 2002;160:1435–1443.
- Chan ACL, Chan JKC, Inagaki H, et al. Thymic extranodal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT). In: Travis WD, Brambilla E, Mueller-Hermelink HK, et al, editors. World Health Organization classification of tumours. Pathology and genetics: tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. pp. 225–226.
- Taby R, Issa JP. Cancer epigenetics and targeted therapies. CA Cancer J Clin 2010;60:376–392.
- Levenson VV. DNA methylation as a universal biomarker. Expert Rev Mol Diagn 2010;10:481–488.
- Shaknovich R, Geng H, Johnson NA, et al. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. Blood 2010;116:e81–e89.
- Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res 2000;61:3225–3229.
- Chan XC. Tumor-suppressive activity of retinoic acid receptor-β in cancer. Cancer Lett 2007;253:14–24.
- Takino H, Li C, Hu S, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol 2008;21:1517–1526.
- Kominato S, Nakayama T, Sato F, et al. Characterization of chromosomal aberrations in thymic MALT lymphoma. Pathol Int 2012;62:93–98.
- Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp. 214–217.
- Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001;158:699–706.
- Du Q. MALT lymphoma: many roads lead to nuclear factor-kb activation. Histopathology 2011;58:26–38.
- Go H, Cho HJ, Paik JH, et al. Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases. Leuk Lymphoma 2011;52:2276–2283.
- Inbal B, Cohen O, Polak-Charcon S, et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997;390:180–184.
- Michie AM, McCaig AM, Nakagawa R, et al. Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS J 2010;277:74–80.
- Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 1999;93:4347–4353.
- Voso MT, Gumiero D, D’Alo’ F, et al. DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. Haematologica 2006;91:1252–1256.
- Rossi D, Capello D, Gloghini A, et al. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004;89:154–164.
- Jacobs G, Hellmig S, Huse K, et al. Polymorphisms in the 3’-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma. Haematologica 2011;96:987–995.
- Shen Y, Winkler IG, Barbier V, et al. Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo. PLoS One 2010;5. pii: e13086.
- Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998;12:845–859.
- Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 2002;21:3475–3495.
- Voorhoeve PM, Agami R. Unraveling human tumor suppressor pathways: a tale of the INK4A locus. Cell Cycle 2004;3:616–620.
- Taniguchi T, Chikatsu N, Takahashi S, et al. Expression of p16INK4A and p14ARF in hematological malignancies. Leukemia 1999;13:1760–1769.
- Paik JH, Jeon YK, Park SS, et al. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas. Histopathology 2005;47:281–291.
- Yee KW, O’Brien SM, Giles FJ. Richter's syndrome: biology and therapy. Cancer J 2005;11:161–174.